Fabtech Technologies Cleanrooms Ltd

Fabtech Technologies Cleanrooms Ltd

₹ 342 -2.27%
11 Jun 10:36 a.m.
About

Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]

Key Points

Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.

  • Market Cap 421 Cr.
  • Current Price 342
  • High / Low 354 / 162
  • Stock P/E 31.6
  • Book Value 76.6
  • Dividend Yield 0.59 %
  • ROCE 21.1 %
  • ROE 18.2 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 27.2% CAGR over last 5 years

Cons

  • Promoter holding has decreased over last quarter: -24.7%
  • The company has delivered a poor sales growth of 10.9% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Sep 2024 Mar 2025
58 62 88
50 55 79
Operating Profit 7 7 9
OPM % 13% 12% 10%
0 0 1
Interest 0 0 0
Depreciation 0 0 0
Profit before tax 7 7 9
Tax % 25% 26% 21%
5 5 8
EPS in Rs 18.34 5.96 6.45
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
89 70 114 125 97 150
83 69 107 112 89 134
Operating Profit 6 1 6 13 9 16
OPM % 7% 2% 5% 10% 9% 11%
1 0 0 0 1 1
Interest 1 0 1 1 1 0
Depreciation 1 1 1 1 0 1
Profit before tax 6 1 5 12 8 16
Tax % 28% -42% 29% 31% 25% 24%
4 1 4 8 6 13
EPS in Rs 1,333.33 250.00 12.92 28.57 20.75 10.80
Dividend Payout % 0% 0% 0% 0% 0% 19%
Compounded Sales Growth
10 Years: %
5 Years: 11%
3 Years: 10%
TTM: 54%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: 55%
TTM: 130%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 17%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.03 0.03 3 3 3 12
Reserves 31 32 35 43 49 82
10 7 8 6 6 1
26 30 36 29 32 28
Total Liabilities 67 69 82 81 89 124
4 5 4 4 5 4
CWIP 0 0 0 0 0 0
Investments 0 0 0 0 1 27
63 64 77 76 83 93
Total Assets 67 69 82 81 89 124

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-9 4 3 8 3 3
2 -1 -4 -3 -2 -26
7 -3 1 -4 -1 24
Net Cash Flow 1 -0 -0 1 0 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 181 221 165 144 193 129
Inventory Days 63 95 63 57 88 67
Days Payable 114 146 105 82 122 74
Cash Conversion Cycle 130 170 123 119 159 122
Working Capital Days 154 179 119 111 156 178
ROCE % 2% 14% 26% 16% 21%

Shareholding Pattern

Numbers in percentages

Mar 2025
68.41%
0.69%
11.24%
19.66%
No. of Shareholders 349

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents